GlassScriptPhysician profile
Gloria Beveridge Herring
NPI 1871080192
$527.56
in general payments reported to CMS, 2019-2025
15 companies · $99.95 in 2025
The $99.95 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.48 · 2022: $181 · 2023: $91.34 · 2024: $84.47 · 2025: $99.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $275.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $89.86 | 2022-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Glaxosmithkline, LLC. | $86.00 | 2022-2025 | Bexsero, Pediarix, Rotarix |
| Corium, LLC | $69.38 | 2021-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $44.50 | 2022-2023 | Jornay Pm |
| Tris Pharma INC | $40.10 | 2021-2022 | |
| Cranial Technologies, INC | $34.92 | 2024-2025 | Doc Band |
| Sanofi Pasteur INC. | $28.07 | 2021-2022 | |
| Verrica Pharmaceuticals INC. | $21.07 | 2024 | Ycanth |
| Teva Pharmaceuticals USA, INC. | $20.07 | 2022 | |
| Collegium Pharmaceutical, INC. | $18.67 | 2025 | Jornay Pm |
| Tolmar, INC. | $16.66 | 2025 | Fensolvi |
| Pfizer INC. | $15.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.13 | 2024 | |
| Adlon Therapeutics L.P. | $14.44 | 2021 | |
| Neos Therapeutics, LP | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Herring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.